The role of melatonin treatment in chronic kidney disease

M Russcher, B Koch, E Nagtegaal, K van der Putten, P Ter Wee, C Gaillard

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)


The pineal hormone melatonin plays a major role in circadian sleep-wake rhythm. Patients with Chronic Kidney Disease (CKD), especially those who are on hemodialysis, frequently suffer from sleep disturbances. In this review an overview is given of the classification of stages of chronic kidney disease, followed by a presentation of the circadian rhythm disorders in renal disease involving sleep disturbances in relation to melatonin deficiency. The therapeutic benefit of melatonin treatment in sleep disorders related to chronic kidney disease including the controlled trials solving this topic, is described. Furthermore, the beneficial effect of melatonin on blood pressure alterations in CKD states and the protection of melatonin in oxidative stress and inflammation in renal disorders are explored. Finally a hypothetic model is described for the relation between circadian rhythm disorders and CKD.
Original languageUndefined/Unknown
Pages (from-to)2644-2656
Number of pages13
JournalFrontiers in Bioscience
Publication statusPublished - 2012
Externally publishedYes

Cite this